公开(公告)号：US20230002472A1

公开(公告)日：2023-01-05

申请号：US16966656

申请日：2019-01-30

Applicant: NEURACLE GENETICS INC.

Inventor： Sang Taek JUNG ,  Kwang-Jin CHUN ,  Ji Yeon HA

IPC: C07K14/705 ,  A61P35/00 ,  C12N15/85

Abstract: The present disclosure relates to a PD-1 variant having improved binding affinity to PD-L1. In addition, the present disclosure relates to a method for preparing the PD-1 variant and a method for screening the PD-1 variant. The PD-1 variant of the present disclosure effectively inhibits the binding between wild-type PD-1 and PD-L1, and thus is expected to have significantly higher penetration ability and anticancer effect by immune cells or therapeutic effect for infectious diseases as compared to existing immune checkpoint inhibitors. At the same time, the possibility of immunogenicity can be minimized. In addition, the convenience of developing biomedicine may be promoted through aglycosylation.